<--- Back to Details
First PageDocument Content
Anticoagulants / Coagulation system / Bristol-Myers Squibb / Heparins / Sanofi / Rivaroxaban / Apixaban / Dabigatran / Prothrombinase / Chemistry / Organic chemistry / Hematology
Anticoagulants
Coagulation system
Bristol-Myers Squibb
Heparins
Sanofi
Rivaroxaban
Apixaban
Dabigatran
Prothrombinase
Chemistry
Organic chemistry
Hematology

Mueck et al. Thrombosis Journal 2013, 11:10 http://www.thrombosisjournal.com/contentREVIEW Open Access

Add to Reading List

Source URL: www.thrombosisjournal.com

Download Document from Source Website

File Size: 624,42 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1vWaT - View Document

Press release  Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi 

Press release Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi 

DocID: 1vq21 - View Document

Press release  Ipsen completes acquisition of select Consumer Healthcare products from Sanofi Paris (France), 8 May 2017 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has completed its previously announce

Press release Ipsen completes acquisition of select Consumer Healthcare products from Sanofi Paris (France), 8 May 2017 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has completed its previously announce

DocID: 1vnbG - View Document

SANOFI WELCOMES  House Policy Coucus KEY FACTS & FIGURES sANoFt

SANOFI WELCOMES House Policy Coucus KEY FACTS & FIGURES sANoFt

DocID: 1v7jN - View Document

A GLOBAL HEALTHCARE COMPANY We are Sanofi CORPORATE PRESENTATION | JUNE

A GLOBAL HEALTHCARE COMPANY We are Sanofi CORPORATE PRESENTATION | JUNE

DocID: 1uQ20 - View Document